Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
NCT06549790
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
124
Enrollment
INDUSTRY
Sponsor class
Conditions
Relapsed/Refractory Acute Myeloid Leukemia
Interventions
DRUG:
NMS-03597812
Sponsor
Nerviano Medical Sciences